Bright Minds Biosciences INC
-$670.1M
Net Activity
Institutions Holding
1
Popularity Rank
#6335
Avg Weight
0.00%
Total Value
$1.4K
Ownership Trend
1 institutions currently hold DRUG, with 0 net buyers and 1 net sellers this quarter.
Institutional Moves
Institutional Moves (Q2 2026)
Significantly Decreased
Based on recent trading activity
Net Selling Institutions
1
Net Buying Institutions
0
Key Holders
Quarterly Activity
Recent Activity
+$0.0
Total Buy Value
$2.4K
Total Sell Value
0
Net Buyers
1
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
No Form 144 planned sale filings in the last 90 days
Beneficial Ownership (13D/13G)
1
Active 5%+ Holders
| Reporting Person | Type | Filing Date | % of Class |
|---|---|---|---|
| Ian McDonald | 13D/A | 2026-07-02 | 13.7% |
Material Events (8-K)
No Form 8-K filings for this ticker
FAQ
Who are the top institutional investors holding BRIGHT MINDS BIOSCIENCES INC (DRUG)?
What is the overall institutional sentiment toward DRUG recently?
Which institutions have been selling or reducing their DRUG positions?
Are there any notable investors adding DRUG to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
601
Total reported value
$20.1B
310 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
563
Total reported value
$25.2B
299 13F institutions increased their position this quarter
Vanguard Growth ETF
Institutions Holding
302
Total reported value
$4.3B
269 13F institutions increased their position this quarter